Results 221 to 230 of about 40,241 (253)

Real-world familiarity with US biosimilar regulatory guidelines and interchangeability state laws among pharmacists and physicians treating immunological disorders. [PDF]

J Manag Care Spec Pharm
Ling YL, Gentile D, Kotomale A, Sharpe JA, Geli D, Gruben D, Omary C, Brackin C, Bailey M.   +8 more
europepmc   +1 more source

Biosimilars and reference biological medicines in the treatment of rheumatoid arthritis: a multicenter cross-sectional study in Catalonia, Spain. [PDF]

Clin Rheumatol
Mas Marin J, Molina-Olano M, Sola NR, Miserachs-Aranda N, Montoliu Alcón P, De Pourcq JT, Quiñones Ribas C, Borràs Trias L, Fernández-Cañabate E, González-Valdivieso J, Figueiredo-Escribá C, Delgado-Hernández R, Braza AJ, Lastra CF, Mariño EL, Modamio P.   +15 more
europepmc   +1 more source

Beyond Cost: Observations on Clinical and Patient Benefits of Biosimilars in Real-World Settings. [PDF]

BioDrugs
Kvien TK, Betteridge N, Brückmann I, Bodenmüller W, Bryn G, Danese S, Gonçalves J, Maravic Z, Thorne C, Wingate L, Cornes P.   +10 more
europepmc   +1 more source

Effectiveness and Safety of Adalimumab Biosimilars in Pediatric Psoriasis: A Multi-Center International Experience. [PDF]

Psoriasis (Auckl)
Bertoli C, Torres T, Romita P, Stingeni L, Hansel K, Mastorino L, Ortoncelli M, Panzone M, Cruz MJ, Bianchi L, Zangrilli A, Musumeci ML, Micali G, Gerbino C, Simonetti O, De Simoni E, Longo C, Mahé E, Di Lernia V.   +18 more
europepmc   +1 more source

Innovative Formulation Strategies for Biosimilars: Trends Focused on Buffer-Free Systems, Safety, Regulatory Alignment, and Intellectual Property Challenges. [PDF]

Pharmaceuticals (Basel)
Bas TG.
europepmc   +1 more source

Adalimumab around the world: comparative analysis of products characteristics and patient support systems. [PDF]

Therap Adv Gastroenterol
Yiu TH, Anderson E, Leung WK, Nakase H, Banerjee R, Lin H, Ma C, Magro F, Tse S, Sands BE, Selinger C, Leong RW.   +11 more
europepmc   +1 more source

Efficacy & safety of adalimumab biosimilar in axial spondyloarthritis: A retrospective study from a tertiary care centre in South India. [PDF]

Indian J Med Res
Gopalan A, Gavali M, Yerram K.
europepmc   +1 more source

Regulierung und adäquate Preisbildung im Markt der Biosimilars: Projekt im Auftrag der Pfizer Deutschland GmbH

, 2017
Altin, Sibel, Bauer, Cosima, May, Uwe, Walendzik, Anke, Wasem, Jürgen, Ziebe, Anissa   +5 more
core